Computed tomography (CT) with iodine-based contrast medium and 18-fluorine-fluorodeoxyglucose positron emission tomography/computed tomography ( Artificial intelligence (AI) is a branch of computer science dedicated to the development of computer algorithms to accomplish tasks traditionally associated with human intelligence. A device mimics cognitive functions, i.e., learning and problem solving, is powered by AI. A popular form of AI is machine learning.18 F-FDG PET/CT) play a crucial role in the diagnosis and staging of lung cancer and mediastinal neoplasms. Magnetic resonance imaging (MRI) with gadolinium-based contrast medium is a complementary tool to CT in lung cancer staging and is extremely useful for the differential diagnosis of mediastinal malignancies. Multimodality imaging also provides key information to guiding interventional diagnostic and therapeutic procedures in the field of lung cancer. Percutaneous ablation therapies (radiofrequency ablation, microwaves and cryoablation) have been widely employed as effective and safe therapeutic options in patients not candidates or refusing surgery. In this context, CT and 18 F-FDG PET/CT are essential for the assessment of adequate tumour ablation, identification of complications, and timely detection of eventual recurrence. Furthermore, other new interventional techniques are emerging as promising options for the locoregional administration of chemotherapeutic agents. This chapter provides an overview of morphological and functional imaging features and applications in the diagnosis and staging of lung and mediastinal malignancies as well as in the assessment of lung cancer after interventional treatments. Interventional diagnostic and treatment options for lung cancer will be discussed, focusing on the multidisciplinary approach and novelties in the field.

Larici, A. R., Cicchetti, G., Iezzi, R., Calandriello, L., Contegiacomo, A., Posa, A., Taralli, S., Triumbari, E. K. A., Calcagni, M. L., Giordano, A., Manfredi, R., Colosimo, C., Lung and Mediastinal Cancer, in Neri, E., Erba, P. A. (ed.), Multimodality Imaging and Intervention in Oncology, Springer International Publishing, Cham 2023: 107- 155. 10.1007/978-3-031-28524-0_7 [https://hdl.handle.net/10807/324556]

Lung and Mediastinal Cancer

Larici, Anna Rita;Cicchetti, Giuseppe;Iezzi, Roberto;Calandriello, Lucio;Contegiacomo, Andrea;Posa, Alessandro;Taralli, Silvia;Calcagni, Maria Lucia;Giordano, Alessandro;Manfredi, Riccardo;Colosimo, Cesare
2023

Abstract

Computed tomography (CT) with iodine-based contrast medium and 18-fluorine-fluorodeoxyglucose positron emission tomography/computed tomography ( Artificial intelligence (AI) is a branch of computer science dedicated to the development of computer algorithms to accomplish tasks traditionally associated with human intelligence. A device mimics cognitive functions, i.e., learning and problem solving, is powered by AI. A popular form of AI is machine learning.18 F-FDG PET/CT) play a crucial role in the diagnosis and staging of lung cancer and mediastinal neoplasms. Magnetic resonance imaging (MRI) with gadolinium-based contrast medium is a complementary tool to CT in lung cancer staging and is extremely useful for the differential diagnosis of mediastinal malignancies. Multimodality imaging also provides key information to guiding interventional diagnostic and therapeutic procedures in the field of lung cancer. Percutaneous ablation therapies (radiofrequency ablation, microwaves and cryoablation) have been widely employed as effective and safe therapeutic options in patients not candidates or refusing surgery. In this context, CT and 18 F-FDG PET/CT are essential for the assessment of adequate tumour ablation, identification of complications, and timely detection of eventual recurrence. Furthermore, other new interventional techniques are emerging as promising options for the locoregional administration of chemotherapeutic agents. This chapter provides an overview of morphological and functional imaging features and applications in the diagnosis and staging of lung and mediastinal malignancies as well as in the assessment of lung cancer after interventional treatments. Interventional diagnostic and treatment options for lung cancer will be discussed, focusing on the multidisciplinary approach and novelties in the field.
2023
Inglese
Multimodality Imaging and Intervention in Oncology
9783031285233
9783031285240
Springer International Publishing
Larici, A. R., Cicchetti, G., Iezzi, R., Calandriello, L., Contegiacomo, A., Posa, A., Taralli, S., Triumbari, E. K. A., Calcagni, M. L., Giordano, A., Manfredi, R., Colosimo, C., Lung and Mediastinal Cancer, in Neri, E., Erba, P. A. (ed.), Multimodality Imaging and Intervention in Oncology, Springer International Publishing, Cham 2023: 107- 155. 10.1007/978-3-031-28524-0_7 [https://hdl.handle.net/10807/324556]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/324556
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact